Fanconi Anemia Complementation Group L Protein [protein FANCL]
topical
2
- Terms
-
FANCL Protein
Fanconi Anemia Group L Complementing Protein
Fanconi Anemia Group L Protein
PHD Finger Protein 9
Ubiquitin Ligase Protein PHF9
Persistent link
https://www.medvik.cz/link/D052240
Definition
An E3 UBIQUITIN LIGASE that plays a key role in the DNA damage response pathway of FANCONI ANEMIA PROTEINS. It is associated with mono-ubiquitination of FANCD2 PROTEIN and the redistribution of FANCD2 to nuclear foci containing BRCA1 PROTEIN.
- DUI
- D052240 MeSH Browser
- CUI
- M0483809
- RN
- EC 2.3.2.27
- History note
- 2006 (2003)
- Public note
- 2006; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN was indexed under LIGASES 2003-2005
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 2
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D08.811.464.938.750.257
Nedd4 Ubiquitin Protein Ligases
D08.811.464.938.750.782
Tripartite Motif-Containing Protein 28
D12.776.313.843
Fanconi Anemia Complementation Group E Protein
D12.776.313.875
Fanconi Anemia Complementation Group F Protein